Buhian, Ednalyn N.

HRN: 22-56-95  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/02/2025
CEFUROXIME 750MG (VIAL)
12/02/2025
12/09/2025
IV
415mg
Q8hours
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines